18 Stocks Moving in Thursday's Pre-Market Session_老虎社区_美港股上老虎

18 Stocks Moving in Thursday's Pre-Market Session

Benzinga2021-12-16

Gainers Calliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

littlekitten
·2021-12-17
.
回复
点赞
举报
Khaye
·2021-12-16
ok
回复
4
举报
ACCY
·2021-12-16
Move it move it 🤗
回复
2
举报
收起
- L1324:
  aye
  2021-12-16
  回复
  举报
Cazim
·2021-12-16
Like 👍
回复
4
举报
收起
- Bluem:
  done
  2021-12-16
  回复
  举报
MyMelody
·2021-12-16
Like
回复
3
举报
Dindindino
·2021-12-16
Good!
回复
4
举报
Doppie
·2021-12-16
Cool
回复
3
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1128981049?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-16 20:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128981049","market":"us","top_or_hot":-1,"title":"18 Stocks Moving in Thursday's Pre-Market Session","media":"Benzinga","content":"<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">网页链接</a>\n\n</div>\n","source":"lsy1606299360108","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PTPI","symbol_name":"Petros Pharmaceuticals, Inc.","start_time":0,"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","article_id":"1128981049","we_media_id":null,"thumbnails":[],"rights":{"source":"lsy1606299360108","url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","pubTimestamp":1639657469,"columns":[],"sourceInfo":{"source_id":"lsy1606299360108","name":"Benzinga"},"weMediaInfo":null,"summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PTPI":"Petros Pharmaceuticals, Inc."},"translate_title":"周四盘前18只股票走势","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GOEV":0.9,"PTPI":0.9},"content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":690561328,"gmtCreate":1639693988487,"gmtModify":1639693988912,"author":{"id":"3584860762907200","authorId":"3584860762907200","name":"littlekitten","avatar":"https://static.tigerbbs.com/ccd59ff6c96999c839e3b5709cfb00ef","vip":1,"crmLevel":12,"crmLevelSwitch":0,"idStr":"3584860762907200","authorIdStr":"3584860762907200"},"htmlText":".","listText":".","text":".","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690561328","repostId":1128981049,"repostType":4,"repost":{"id":"1128981049","kind":"news","pubTimestamp":1639657469,"share":"https://www.laohu8.com/m/news/1128981049?lang=&edition=full","pubTime":"2021-12-16 20:24","market":"us","language":"en","title":"18 Stocks Moving in Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","media":"Benzinga","summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","content":"<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128981049","content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","news_type":1,"symbols_score_info":{"GOEV":0.9,"PTPI":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690870690,"gmtCreate":1639658878147,"gmtModify":1639658878522,"author":{"id":"3576190458868886","authorId":"3576190458868886","name":"Khaye","avatar":"https://static.tigerbbs.com/efc4560ea443052d38c11ae66e7c5c0a","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3576190458868886","authorIdStr":"3576190458868886"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690870690","repostId":1128981049,"repostType":4,"repost":{"id":"1128981049","kind":"news","pubTimestamp":1639657469,"share":"https://www.laohu8.com/m/news/1128981049?lang=&edition=full","pubTime":"2021-12-16 20:24","market":"us","language":"en","title":"18 Stocks Moving in Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","media":"Benzinga","summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","content":"<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128981049","content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","news_type":1,"symbols_score_info":{"GOEV":0.9,"PTPI":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690847595,"gmtCreate":1639658786017,"gmtModify":1639658800189,"author":{"id":"3579758808989513","authorId":"3579758808989513","name":"ACCY","avatar":"https://static.tigerbbs.com/a44626552831eb06aa01cf85dcaf7422","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3579758808989513","authorIdStr":"3579758808989513"},"htmlText":"Move it move it 🤗","listText":"Move it move it 🤗","text":"Move it move it 🤗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690847595","repostId":1128981049,"repostType":4,"repost":{"id":"1128981049","kind":"news","pubTimestamp":1639657469,"share":"https://www.laohu8.com/m/news/1128981049?lang=&edition=full","pubTime":"2021-12-16 20:24","market":"us","language":"en","title":"18 Stocks Moving in Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","media":"Benzinga","summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","content":"<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128981049","content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","news_type":1,"symbols_score_info":{"GOEV":0.9,"PTPI":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7009883,"gmtCreate":1639668356296,"gmtModify":1639668356328,"authorId":3574119575606145,"author":{"id":3574119575606145,"idStr":"3574119575606145","authorId":3574119575606145,"name":"L1324","avatar":"https://static.tigerbbs.com/b05b9f32dd8af2590c80da38d48e37fc","vip":1,"crmLevel":12,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690847595,"type":1,"supId":0,"prevId":0,"content":"<u>aye</u>","text":"<u>aye</u>","html":"<u>aye</u>"}],"langContent":"CN"},{"id":690849122,"gmtCreate":1639657993487,"gmtModify":1639657993590,"author":{"id":"3581995984866169","authorId":"3581995984866169","name":"Cazim","avatar":"https://static.tigerbbs.com/03daf3108334a470539d645110a7afbb","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3581995984866169","authorIdStr":"3581995984866169"},"htmlText":"Like 👍&nbsp;","listText":"Like 👍&nbsp;","text":"Like 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690849122","repostId":1128981049,"repostType":4,"repost":{"id":"1128981049","kind":"news","pubTimestamp":1639657469,"share":"https://www.laohu8.com/m/news/1128981049?lang=&edition=full","pubTime":"2021-12-16 20:24","market":"us","language":"en","title":"18 Stocks Moving in Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","media":"Benzinga","summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","content":"<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128981049","content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","news_type":1,"symbols_score_info":{"GOEV":0.9,"PTPI":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7006479,"gmtCreate":1639658061739,"gmtModify":1639658061847,"authorId":3575980094521663,"author":{"id":3575980094521663,"idStr":"3575980094521663","authorId":3575980094521663,"name":"Bluem","avatar":"https://static.tigerbbs.com/2ea0046117889d9c87b13a313a480e69","vip":1,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":690849122,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"CN"},{"id":690840236,"gmtCreate":1639657938432,"gmtModify":1639657938832,"author":{"id":"4097904547274900","authorId":"4097904547274900","name":"MyMelody","avatar":"https://static.tigerbbs.com/d6cd6a7b09f47978b230dcda643836b8","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"4097904547274900","authorIdStr":"4097904547274900"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690840236","repostId":1128981049,"repostType":4,"repost":{"id":"1128981049","kind":"news","pubTimestamp":1639657469,"share":"https://www.laohu8.com/m/news/1128981049?lang=&edition=full","pubTime":"2021-12-16 20:24","market":"us","language":"en","title":"18 Stocks Moving in Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","media":"Benzinga","summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","content":"<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128981049","content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","news_type":1,"symbols_score_info":{"GOEV":0.9,"PTPI":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690840935,"gmtCreate":1639657892580,"gmtModify":1639657892831,"author":{"id":"3585008979244156","authorId":"3585008979244156","name":"Dindindino","avatar":"https://static.tigerbbs.com/8aa54f4d7f1ed33d80d2d8d18918fb30","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"3585008979244156","authorIdStr":"3585008979244156"},"htmlText":"Good!&nbsp;","listText":"Good!&nbsp;","text":"Good!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690840935","repostId":1128981049,"repostType":4,"repost":{"id":"1128981049","kind":"news","pubTimestamp":1639657469,"share":"https://www.laohu8.com/m/news/1128981049?lang=&edition=full","pubTime":"2021-12-16 20:24","market":"us","language":"en","title":"18 Stocks Moving in Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","media":"Benzinga","summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","content":"<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128981049","content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","news_type":1,"symbols_score_info":{"GOEV":0.9,"PTPI":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":690857808,"gmtCreate":1639657840694,"gmtModify":1639657840781,"author":{"id":"4089595132650310","authorId":"4089595132650310","name":"Doppie","avatar":"https://static.tigerbbs.com/7b27ed4372346d792999c32f5ed31a02","vip":1,"crmLevel":11,"crmLevelSwitch":0,"idStr":"4089595132650310","authorIdStr":"4089595132650310"},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690857808","repostId":1128981049,"repostType":4,"repost":{"id":"1128981049","kind":"news","pubTimestamp":1639657469,"share":"https://www.laohu8.com/m/news/1128981049?lang=&edition=full","pubTime":"2021-12-16 20:24","market":"us","language":"en","title":"18 Stocks Moving in Thursday's Pre-Market Session","url":"https://stock-news.laohu8.com/highlight/detail?id=1128981049","media":"Benzinga","summary":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company ann","content":"<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>18 Stocks Moving in Thursday's Pre-Market Session</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n18 Stocks Moving in Thursday's Pre-Market Session\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 20:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PTPI":"Petros Pharmaceuticals, Inc."},"source_url":"https://www.benzinga.com/news/21/12/24640676/18-stocks-moving-in-thursdays-pre-market-session","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128981049","content_text":"Gainers\n\nCalliditas Therapeutics AB rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO to reduce proteinuria in lgA nephropathy.\nCooTek (Cayman) Inc. rose 15.6% to $0.5589 in pre-market trading after dropping more than 10% on Wednesday.\nPetros Pharmaceuticals, Inc. rose 13.5% to $3.26 in pre-market trading after gaining over 4% on Wednesday.\nAmerican Virtual Cloud Technologies, Inc. rose 13.5% to $1.74 in pre-market trading after the company’s Kandy Communications business unit said that full Public Switched Telephone Network (PSTN) replacement services are now available in Brazil and China.\nRetail Value Inc. rose 12.2% to $6.80 in pre-market trading after the company reported the sale of Willowbrook Plaza. The company reported a special common share distribution and preferred stock repurchase.\nTyme Technologies, Inc. rose 10.3% to $0.8165 in pre-market trading. TYME Technologies recently said TYME-19 'demonstrated an antiviral effect against SARS CoV-2 in human lung epithelial cells.'\nAssertio Holdings, Inc. rose 9.6% to $1.48 in pre-market trading after the company reported the acquisition of Otrexup® (methotrexate) a drug device combination from Antares Pharma, Inc.\nEnveric Biosciences, Inc. rose 7.5% to $1.14 in pre-market trading after declining over 6% on Wednesday.\nCo-Diagnostics, Inc. rose 7.2% to $8.92 in pre-market trading. Co-Diagnostics reported a partnership with TiiCKER to 'increase its connection to retail investors.'\nCanoo Inc. rose 6.9% to $9.24 in pre-market trading after the company boosted production guidance and targets for US facilities.\nHUTCHMED (China) Limited rose 6.9% to $34.09 in pre-market trading.\nLegend Biotech Corporation rose 6.7% to $43.90 in pre-market trading. Legend Biotech recently reported an offering of $300 million in ADSs.\nNavidea Biopharmaceuticals, Inc. rose 6% to $1.23 in pre-market trading. Navidea Biopharmaceuticals terminated purchase agreement of $25 million worth of stock. The company also completed full enrollment in Phase 2b normative database study to support its rheumatoid arthritis program.\n\nLosers\n\nIronNet, Inc. fell 19.3% to $5.49 in pre-market trading after the company reported Q3 sales results were lower year over year.\nZhangmen Education Inc. fell 8.2% to $1.12 in pre-market trading.\nLennar Corporation shares fell 7.2% to $105.00 in pre-market trading after the company reported downbeat earnings for its fourth quarter. The company said it sees Q1 new orders of 14,800 to 15,100.\nDanimer Scientific, Inc. shares fell 6.5% to $9.90 in pre-market trading after the company reported a proposed convertible senior notes offering.\nInpixon fell 6.2% to $0.67 in pre-market trading after gaining around 7% on Wednesday.","news_type":1,"symbols_score_info":{"GOEV":0.9,"PTPI":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":66,"commentSize":7,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}